SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,665,628 | +9.8% | 21,990 | +3.8% | 0.00% | 0.0% |
| Q2 2023 | $2,427,252 | -16.2% | 21,195 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $2,898,151 | -4.4% | 21,027 | -10.2% | 0.00% | 0.0% |
| Q4 2022 | $3,032,949 | +37.7% | 23,406 | +17.5% | 0.00% | 0.0% |
| Q3 2022 | $2,202,000 | +37.3% | 19,914 | -6.9% | 0.00% | +100.0% |
| Q2 2022 | $1,604,000 | +17.6% | 21,395 | +22.6% | 0.00% | 0.0% |
| Q1 2022 | $1,364,000 | -18.7% | 17,454 | -6.3% | 0.00% | 0.0% |
| Q4 2021 | $1,677,000 | -23.8% | 18,626 | -21.7% | 0.00% | 0.0% |
| Q3 2021 | $2,201,000 | +5.7% | 23,799 | -11.1% | 0.00% | 0.0% |
| Q2 2021 | $2,082,000 | +4.0% | 26,782 | -0.2% | 0.00% | 0.0% |
| Q1 2021 | $2,001,000 | -53.7% | 26,845 | +6.0% | 0.00% | -66.7% |
| Q4 2020 | $4,320,000 | +22.4% | 25,337 | +0.8% | 0.00% | 0.0% |
| Q3 2020 | $3,529,000 | -19.2% | 25,128 | -7.8% | 0.00% | -25.0% |
| Q2 2020 | $4,368,000 | +129.7% | 27,241 | +40.1% | 0.00% | +100.0% |
| Q1 2020 | $1,902,000 | -21.0% | 19,438 | +4.1% | 0.00% | 0.0% |
| Q4 2019 | $2,409,000 | +70.2% | 18,675 | -0.5% | 0.00% | +100.0% |
| Q3 2019 | $1,415,000 | -56.8% | 18,777 | -12.9% | 0.00% | -66.7% |
| Q2 2019 | $3,275,000 | +35.8% | 21,560 | +6.5% | 0.00% | +50.0% |
| Q1 2019 | $2,411,000 | +27.7% | 20,240 | +17.0% | 0.00% | 0.0% |
| Q4 2018 | $1,888,000 | -39.4% | 17,302 | -10.4% | 0.00% | -33.3% |
| Q3 2018 | $3,118,000 | +27.3% | 19,305 | +4.2% | 0.00% | +50.0% |
| Q2 2018 | $2,449,000 | +65.7% | 18,528 | -7.1% | 0.00% | +100.0% |
| Q1 2018 | $1,478,000 | +36.9% | 19,946 | +2.7% | 0.00% | 0.0% |
| Q4 2017 | $1,080,000 | +168.7% | 19,416 | +118.8% | 0.00% | – |
| Q3 2017 | $402,000 | +29.7% | 8,873 | -3.5% | 0.00% | – |
| Q2 2017 | $310,000 | +10.7% | 9,199 | -2.7% | 0.00% | – |
| Q1 2017 | $280,000 | +9.4% | 9,455 | +1.4% | 0.00% | – |
| Q4 2016 | $256,000 | -45.2% | 9,326 | +22.6% | 0.00% | -100.0% |
| Q3 2016 | $467,000 | +56.7% | 7,606 | -1.5% | 0.00% | – |
| Q4 2015 | $298,000 | +32.4% | 7,722 | +10.1% | 0.00% | – |
| Q3 2015 | $225,000 | +35.5% | 7,016 | -38.9% | 0.00% | – |
| Q4 2014 | $166,000 | -34.1% | 11,479 | +35.8% | 0.00% | – |
| Q2 2014 | $252,000 | +0.8% | 8,454 | -18.6% | 0.00% | – |
| Q1 2014 | $250,000 | -46.8% | 10,384 | +4.4% | 0.00% | -100.0% |
| Q3 2013 | $470,000 | +16.6% | 9,948 | -6.2% | 0.00% | 0.0% |
| Q2 2013 | $403,000 | – | 10,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |